A detailed history of Baker Avenue Asset Management, LP transactions in Amgen Inc stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 3,212 shares of AMGN stock, worth $910,955. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,212
Previous 1,550 107.23%
Holding current value
$910,955
Previous $484,000 113.64%
% of portfolio
0.03%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$309.38 - $337.38 $514,189 - $560,725
1,662 Added 107.23%
3,212 $1.03 Million
Q2 2024

Aug 07, 2024

BUY
$262.75 - $319.31 $18,392 - $22,351
70 Added 4.73%
1,550 $484,000
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $4,301 - $5,192
16 Added 1.09%
1,480 $420,000
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $1,534 - $1,730
6 Added 0.41%
1,464 $421,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $15,086 - $18,730
69 Added 4.97%
1,458 $391,000
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $10,927 - $12,921
-51 Reduced 3.54%
1,389 $308,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $677 - $825
-3 Reduced 0.21%
1,440 $348,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $46,264 - $58,784
-202 Reduced 12.28%
1,443 $378,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $30,526 - $34,428
136 Added 9.01%
1,645 $371,000
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $112,586 - $125,289
488 Added 47.8%
1,509 $367,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $228,040 - $252,272
-1,040 Reduced 50.46%
1,021 $247,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $50,913 - $58,265
256 Added 14.18%
2,061 $464,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $200,170 - $234,524
943 Added 109.4%
1,805 $383,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $5,605 - $6,219
-24 Reduced 2.71%
862 $210,000
Q4 2020

Feb 17, 2021

SELL
$216.38 - $257.67 $4.49 Million - $5.35 Million
-20,769 Reduced 95.91%
886 $203,000
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $80,954 - $90,027
345 Added 1.62%
21,655 $5.5 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $321,441 - $394,452
-1,625 Reduced 7.09%
21,310 $5.03 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $1.93 Million - $2.55 Million
-10,567 Reduced 31.54%
22,935 $4.65 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $214,564 - $275,788
-1,134 Reduced 3.27%
33,502 $8.08 Million
Q3 2019

Nov 15, 2019

SELL
$174.11 - $208.62 $268,651 - $321,900
-1,543 Reduced 4.26%
34,636 $6.7 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $193,705 - $227,066
-1,162 Reduced 3.11%
36,179 $6.67 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $157,718 - $177,783
-872 Reduced 2.28%
37,341 $7.09 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $81,885 - $95,586
-459 Reduced 1.19%
38,213 $7.44 Million
Q3 2018

Nov 15, 2018

BUY
$185.29 - $208.89 $281,084 - $316,886
1,517 Added 4.08%
38,672 $8.02 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $135,330 - $152,005
815 Added 2.24%
37,155 $6.86 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $6,777 - $7,920
40 Added 0.11%
36,340 $6.2 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $372,013 - $415,652
2,204 Added 6.46%
36,300 $6.31 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $158,758 - $181,259
949 Added 2.86%
34,096 $6.36 Million
Q2 2017

Aug 11, 2017

BUY
N/A
33,147
33,147 $5.71 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.